Class II · Moderate risk Terminated
Zonisamide Capsules USP
Reason CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Zonisamide Capsules USP
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
cGMP deviations
What was recalled
Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-128-01
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- NDC code
- 68462-128-01
- Origin
- NJ, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-0791-2022
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Zonisamide recalls
See all
Class II · Moderate risk Completed
Zonisamide Capsules
Reason cGMP deviations
Class II · Moderate risk Completed
Zonisamide Capsules
Reason cGMP deviations
Class II · Moderate risk Terminated
Zonisamide 100 mg Capsules
Reason CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.
Class II · Moderate risk Terminated
Zonisamide Capsules USP 100 mg Rx Only Manufactured by: Glenmark…
Reason CGMP Deviations
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.